On Saturday 17 March 2017 a warrior for justice – Jaitun – commonly referred to as ‘Amma’, took her last breath and with the stillness of the night, like a rainbow that came to show her magnificence, her spirit passed on as her body lay on a scrap of mud floor outside a shop front, which she paid Rupees 1,500 per month to rent…
Unsafe abortion is still a significant public health problem in India, with complications of abortion accounting for 8-9% of maternal deaths. Every year an estimated 6.4 million abortions take place in India, and over half (56%) are estimated to be unsafe. Many women are not aware that abortion is legal, nor are they aware of facilities that are certified by the government to provide abortion services.
Background: Abortion services were legalized in India in 1972, however, the access to safe abortion services is restricted, especially in rural areas. In 2002, medical abortion using mifepristone- misoprostol was approved for termination of pregnancy, however, its use has been limited in primary care settings.
Although home use of misoprostol for early medical abortion is considered to be safe, effective and feasible, it has not become standard service delivery practice [in India]. The aim of this study was to compare the efficacy, safety, and acceptability of home use of misoprostol as compared to clinic misoprostol in a low-resource setting.
This report, published in November 2016 by the Centre for Health Law, Ethics and Technology at Jindal Global Law School, in collaboration with the Ipas Development Foundation India, aims to clarify provisions of the Medical Termination of Pregnancy Act 1971 (MTP Act), to highlight contradictions and gaps in the MTP Act and related laws, including the Pre-Conception Pre-Natal Diagnostic Techniques Act, 1994 (PCPNDT Act) and the Protection of Children from Sexual Offenses Act, 2012 (POCSO Act), … Continued